3 recruiting, 2 completed, 1 not yet recruiting. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Recruiting 3, Completed 2, Not yet recruiting 1 |
Follow netarsudil: new trials by email Literature Review of netarsudil trials Research Report on netarsudil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA], Timolol Maleate 0.25% Ophthalmic Solution - Open Angle Glaucoma (OAG), Glaucoma | Phase 4 | Recruiting | Brett King | 13 | 2026-10-01 | 2026-10-28 |
| Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects Rocklatan (Netarsudil 0.02%/ latanoprost 0.005), Latanoprost (0.005%) - Ocular Hypertension, Suspect Glaucoma | Phase 4 | Recruiting | University of Maryland, Baltimore | 50 | 2026-07-02 | 2026-07-02 |
| 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients Netarsudil 0.02%/latanoprost 0.005% fixed dose combination ophthalmic solution, Latanoprost 0.005% Ophthalmic Solution - Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Recruiting | Mayo Clinic | 30 | 2025-11-21 | 2026-05-01 |
| Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery) Rocklatan (netarsudil 0.02% and latanoprost 0.005%), Systane - Primary Open Angle Glaucoma | Phase 4 | Not yet recruiting | Center for Sight Las Vegas | 68 | 2025-07-15 | 2025-07-03 |
| Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost Netarsudil, Brimonidine - Normal Tension Glaucoma | Phase 4 | Completed | Westlake Eye Specialists | 100 | 2024-06-13 | 2025-10-22 |
| Rocklatan® Evaluation Netarsudil 0.02%/latanoprost 0.005% fixed dose combination ophthalmic solution - Glaucoma | Phase 4 | Completed | Aerie Pharmaceuticals | 136 | 2022-03-28 | 2024-04-03 |
Glaucoma, Open-Angle (3) · Glaucoma (2) · Ocular Hypertension (2) · Low Tension Glaucoma (1)
Aerie Pharmaceuticals (1) · Brett King (1) · Center for Sight Las Vegas (1) · Mayo Clinic (1) · University of Maryland, Baltimore (1) · Westlake Eye Specialists (1)
United States (6)
Arthur J Sit, MD, MS (1) · Osamah Saeedi, MD (1) · Scientific Advisor, Clinical R&D (1) · Zarmeena Vendal, MD (1)